ABOUT THIS EPISODE
Explore how AI is transforming drug discovery. Learn how generative and agentic AI, data integration, and workflow optimization can accelerate research, overcome challenges, and drive collaboration in pharmaceutical R&D.
English
United States
TRANSCRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
OTHER EPISODES IN THIS PODCAST
The relatively high failure rate of new candidate drugs is a key issue in pharma and biopharma R&D. Listen in as we discuss how artificial intelligence, machine learning, and the ever-increasing availability of biological datasets can improve prospects.
Digital therapeutics are software-driven, evidence-based products used to prevent, manage, or treat a medical disease or disorder. Digital therapeutics enable patients to be more aware of and play a more active role in managing their health and can improve access for patients for whom visiting a cl…
Early detection of cancer and other diseases can significantly improve patient prognosis. Join us for a practical discussion about the challenges of developing noninvasive early screening tools, from biomarker identification to clinical performance.
Precision medicine is a multifaceted approach to designing and delivering individualized patient treatments. Using multi-omic, environmental, lifestyle, and other data, researchers aim to more accurately develop treatment and prevention strategies tailored to each unique patient. The promise of pre…
From antibiotics to cancer drugs, fungi and other microbes have long been a rich source of medicinal compounds. In this episode, we discuss how one company sequences and mines novel fungal genomes to discover and engineer new therapeutics.
Disclaimer: The podcast and artwork embedded on this page are from Bio-Rad Laboratories, Inc., which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.
